Literature DB >> 4045217

Lamellar body-enriched fractions from neonatal mice: preparative techniques and partial characterization.

S Grayson, A G Johnson-Winegar, B U Wintroub, R R Isseroff, E H Epstein, P M Elias.   

Abstract

Several problems have frustrated the isolation of lamellar bodies (LB) from mammalian epidermis. We obtained pellets enriched in intact LB by utilizing the staphylococcal epidermolytic toxin to provide intact, outer epidermal sheets, by controlled homogenization in a cell disrupter, and by passage of homogenates through a graded series of nuclepore filters (Science 221:962, 1983). Such preparations contained more intact LB than did fractions prepared by a variety of differential or sucrose/metrizamide discontinuous centrifugation methods. Initial characterization of the enzymatic content of this fraction revealed it to be enriched in certain hydrolytic enzymes (acid phosphatase, carboxypeptidase, cathepsin B, acid lipase, sphingomyelinase, and phospholipase A), but strikingly depleted in all sulfatases, beta-glucuronidase, and the non-lysosomal protease, plasminogen activator. Thus, LB show some properties of lysosomes, although certain characteristic lysosomal enzymes are strikingly absent. Lamellar body fractions contained 2-3 times more lipid per unit weight than did homogenates, and were enriched in phospholipids, free sterols, and glycosphingolipids, but not in other neutral lipids or ceramides. In summary, whereas some of the enzymes in LB could participate in the metabolism of LB lipid precursors to hydrophobic barrier constituents, others may attack intercellular constituents, ultimately resulting in desquamation. The lipid profile of these organelles suggests that they deliver precursors of permeability barrier lipids to intercellular domains.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4045217     DOI: 10.1111/1523-1747.ep12276826

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  41 in total

Review 1.  The importance of the lipoxygenase-hepoxilin pathway in the mammalian epidermal barrier.

Authors:  Agustí Muñoz-Garcia; Christopher P Thomas; Diane S Keeney; Yuxiang Zheng; Alan R Brash
Journal:  Biochim Biophys Acta       Date:  2013-09-07

2.  Lipokeratinocytes of the epidermis of a cetacean (Phocena phocena). Histochemistry, ultrastructure, and lipid composition.

Authors:  G K Menon; S Grayson; B E Brown; P M Elias
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

Review 3.  The epidermal permeability barrier.

Authors:  L Landmann
Journal:  Anat Embryol (Berl)       Date:  1988

Review 4.  Ceramide signaling in mammalian epidermis.

Authors:  Yoshikazu Uchida
Journal:  Biochim Biophys Acta       Date:  2013-09-19

5.  Desmosomes, corneosomes and desquamation. An ultrastructural study of adult pig epidermis.

Authors:  S J Chapman; A Walsh
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

Review 6.  Organization, barrier function and antimicrobial lipids of the oral mucosa.

Authors:  D V Dawson; D R Drake; J R Hill; K A Brogden; C L Fischer; P W Wertz
Journal:  Int J Cosmet Sci       Date:  2013-02-09       Impact factor: 2.970

Review 7.  The epidermolytic (exfoliative) toxins of Staphylococcus aureus.

Authors:  C J Bailey; B P Lockhart; M B Redpath; T P Smith
Journal:  Med Microbiol Immunol       Date:  1995-08       Impact factor: 3.402

Review 8.  Role of cholesterol sulfate in epidermal structure and function: lessons from X-linked ichthyosis.

Authors:  Peter M Elias; Mary L Williams; Eung-Ho Choi; Kenneth R Feingold
Journal:  Biochim Biophys Acta       Date:  2013-11-27

Review 9.  Pathobiology of the stratum corneum.

Authors:  S M Jackson; M L Williams; K R Feingold; P M Elias
Journal:  West J Med       Date:  1993-03

10.  Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function.

Authors:  W M Holleran; Y Takagi; G K Menon; G Legler; K R Feingold; P M Elias
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.